financetom
Business
financetom
/
Business
/
Jamf Holding Insider Sold Shares Worth $1,032,278, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Jamf Holding Insider Sold Shares Worth $1,032,278, According to a Recent SEC Filing
May 8, 2024 1:08 AM

03:57 AM EDT, 05/08/2024 (MT Newswires) -- Ian Goodkind, Chief Financial Officer, on May 03, 2024, sold 51,439 shares in Jamf Holding ( JAMF ) for $1,032,278. Following the Form 4 filing with the SEC, Goodkind has control over a total of 244,699 shares of the company, with 244,699 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1721947/000156218024003881/xslF345X03/primarydocument.xml

Price: 20.59, Change: -0.41, Percent Change: -1.95

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Stack Capital Group Invests US$10 Million in CoreWeave
Stack Capital Group Invests US$10 Million in CoreWeave
Mar 5, 2025
08:10 AM EST, 03/05/2025 (MT Newswires) -- Stack Capital Group ( STCGF ) on Wednesday said it has invested US$10 million into CoreWeave, a cloud-based AI-infrastructure company that provides data centers delivering high-performance capabilities. Given its growing data center presence across the United States, Europe, and Canada, CoreWeave is extremely well-positioned to continue capitalizing on accelerating global demand for AI...
Novo Nordisk to offer lower-priced versions of Wegovy for cash-paying customers
Novo Nordisk to offer lower-priced versions of Wegovy for cash-paying customers
Mar 5, 2025
March 5 (Reuters) - Novo Nordisk said on Wednesday it would offer lower-priced doses of its weight loss drug Wegovy at a reduced cost of $499 per month for cash-paying customers. The offer will be available for uninsured patients or eligible patients with commercial insurance who do not have coverage for obesity medicines, the company said. ...
Axsome Therapeutics Resolves Sunosi Patent Case With Hikma
Axsome Therapeutics Resolves Sunosi Patent Case With Hikma
Mar 5, 2025
08:06 AM EST, 03/05/2025 (MT Newswires) -- Axsome Therapeutics ( AXSM ) said Wednesday it has reached a settlement with Hikma Pharmaceuticals resolving a patent dispute over its treatment Sunosi (solriamfetol.) The dispute arose after Hikma filed an abbreviated new drug application seeking Food and Drug Administration approval to produce a generic version of Sunosi, the company said. As part...
CareRx Q4 Net Loss Narrows, Adjusted Profit Beats Estimate
CareRx Q4 Net Loss Narrows, Adjusted Profit Beats Estimate
Mar 5, 2025
08:08 AM EST, 03/05/2025 (MT Newswires) -- CareRx ( CHHHF ) , which provides pharmacy services to seniors in care communities, on Wednesday said its fourth-quarter net loss narrowed and adjusted earnings per share beat estimates. The net loss came in at $2.2 million or $0.04 per share, compared with a net loss of $3.7 million or $0.06 per share,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved